Literature DB >> 22827375

Targeted gene silencing to induce permanent sterility.

G A Dissen1, A Lomniczi, R L Boudreau, Y H Chen, B L Davidson, S R Ojeda.   

Abstract

A non-surgical method to induce sterility would be a useful tool to control feral populations of animals. Our laboratories have experience with approaches aimed at targeting brain cells in vivo with vehicles that deliver a payload of either inhibitory RNAs or genes intended to correct cellular dysfunction. A combination/modification of these methods may provide a useful framework for the design of approaches that can be used to sterilize cats and dogs. For this approach to succeed, it has to meet several conditions: it needs to target a gene essential for fertility. It must involve a method that can selectively silence the gene of interest. It also needs to deliver the silencing agent via a minimally invasive method. Finally, the silencing effect needs to be sustained for many years, so that expansion of the targeted population can be effectively prevented. In this article, we discuss this subject and provide a succinct account of our previous experience with: (i) molecular reagents able to disrupt reproductive cyclicity when delivered to regions of the brain involved in the control of reproduction and (ii) molecular reagents able to ameliorate neuronal disease when delivered systemically using a novel approach of gene therapy.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22827375      PMCID: PMC3516287          DOI: 10.1111/j.1439-0531.2012.02080.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  50 in total

Review 1.  Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion.

Authors:  Michael N Lehman; Lique M Coolen; Robert L Goodman
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 2.  Adeno-associated virus serotypes: vector toolkit for human gene therapy.

Authors:  Zhijian Wu; Aravind Asokan; R Jude Samulski
Journal:  Mol Ther       Date:  2006-07-07       Impact factor: 11.454

3.  Neurokinin B and dynorphin A in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile gonadotropin-releasing hormone secretion in the goat.

Authors:  Yoshihiro Wakabayashi; Tomoaki Nakada; Ken Murata; Satoshi Ohkura; Kazutaka Mogi; Victor M Navarro; Donald K Clifton; Yuji Mori; Hiroko Tsukamura; Kei-Ichiro Maeda; Robert A Steiner; Hiroaki Okamura
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

4.  TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction.

Authors:  A Kemal Topaloglu; Frank Reimann; Metin Guclu; Ayse Serap Yalin; L Damla Kotan; Keith M Porter; Ayse Serin; Neslihan O Mungan; Joshua R Cook; Sazi Imamoglu; N Sema Akalin; Bilgin Yuksel; Stephen O'Rahilly; Robert K Semple
Journal:  Nat Genet       Date:  2008-12-11       Impact factor: 38.330

5.  KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction.

Authors:  F Gaytán; M Gaytán; J M Castellano; M Romero; J Roa; B Aparicio; N Garrido; J E Sánchez-Criado; R P Millar; A Pellicer; H M Fraser; M Tena-Sempere
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

6.  Distribution of kisspeptin neurones in the adult female mouse brain.

Authors:  J Clarkson; X d'Anglemont de Tassigny; W H Colledge; A Caraty; A E Herbison
Journal:  J Neuroendocrinol       Date:  2009-06-08       Impact factor: 3.627

Review 7.  Clinical gene therapy using recombinant adeno-associated virus vectors.

Authors:  C Mueller; T R Flotte
Journal:  Gene Ther       Date:  2008-04-17       Impact factor: 5.250

8.  Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge.

Authors:  Jenny Clarkson; Xavier d'Anglemont de Tassigny; Adriana Santos Moreno; William H Colledge; Allan E Herbison
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

9.  Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene.

Authors:  Xavier d'Anglemont de Tassigny; Lisa A Fagg; John P C Dixon; Kate Day; Harry G Leitch; Alan G Hendrick; Dirk Zahn; Isabelle Franceschini; Alain Caraty; Mark B L Carlton; Samuel A J R Aparicio; William H Colledge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

10.  Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy.

Authors:  Yong Hong Chen; Michael Chang; Beverly L Davidson
Journal:  Nat Med       Date:  2009-09-13       Impact factor: 53.440

View more
  2 in total

1.  Engineering a gene silencing viral construct that targets the cat hypothalamus to induce permanent sterility: An update.

Authors:  G A Dissen; K Adachi; A Lomniczi; T Chatkupt; B L Davidson; H Nakai; S R Ojeda
Journal:  Reprod Domest Anim       Date:  2016-11-17       Impact factor: 2.005

2.  Epigenetic repression of gonadotropin gene expression via a GnRH-mediated DNA delivery system.

Authors:  Lilach Pnueli; Philippa Melamed
Journal:  Gene Ther       Date:  2022-03-17       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.